Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-10 4:21 pm Sale |
2022-12-31 | 13G | Intersect ENT, Inc. XENT |
Versor Investments LP | 0 0.000% |
-3,347,165 (Position Closed) |
Filing History |
| 2022-03-11 2:13 pm Unchanged |
2021-12-31 | 13G | Intersect ENT, Inc. XENT |
BLACKROCK INC BLK |
2,638,333 7.900% |
0 (Unchanged) |
Filing History |
| 2022-02-23 08:56 am Sale |
2022-02-14 | 13G | Intersect ENT, Inc. XENT |
Versor Investments LP | 3,347,165 10.000% |
-21,926 (-0.65%) |
Filing History |
| 2022-02-17 11:40 am Purchase |
2022-02-07 | 13G | Intersect ENT, Inc. XENT |
Versor Investments LP | 3,369,091 10.070% |
193,994 (+6.11%) |
Filing History |
| 2022-02-14 4:41 pm Purchase |
2021-12-31 | 13G | Intersect ENT, Inc. XENT |
First Light Asset Management, LLC | 1,381,710 4.130% |
1,381,710 (New Position) |
Filing History |
| 2022-02-10 08:17 am Purchase |
2021-12-31 | 13G | Intersect ENT, Inc. XENT |
The Vanguard Group | 1,801,606 5.380% |
136,172 (+8.18%) |
Filing History |
| 2022-02-08 5:05 pm Sale |
2021-12-31 | 13G | Intersect ENT, Inc. XENT |
BLACKROCK INC BLK |
2,638,333 7.900% |
-247,443 (-8.57%) |
Filing History |
| 2022-02-08 11:14 am Purchase |
2021-12-31 | 13G | Intersect ENT, Inc. XENT |
Versor Investments LP | 3,175,097 9.500% |
1,439,018 (+82.89%) |
Filing History |
| 2022-01-31 2:34 pm Purchase |
2021-12-31 | 13G | Intersect ENT, Inc. XENT |
GOLDMAN SACHS GROUP INC GS |
2,628,508 7.900% |
2,628,508 (New Position) |
Filing History |
| 2021-10-20 4:41 pm Purchase |
2021-10-11 | 13G | Intersect ENT, Inc. XENT |
Integrated Core Strategies (US) LLC | 1,630,168 4.900% |
1,586,545 (+3636.95%) |
Filing History |
| 2021-10-08 06:18 am Sale |
2021-09-30 | 13G | Intersect ENT, Inc. XENT |
Artisan Partners Limited Partnership | 1,454,164 4.400% |
-2,314,007 (-61.41%) |
Filing History |
| 2021-09-10 09:33 am Sale |
2021-09-09 | 13G | Intersect ENT, Inc. XENT |
FMR CORP | 0 0.000% |
-3,495,000 (Position Closed) |
Filing History |
| 2021-08-19 08:46 am Purchase |
2021-08-09 | 13D | Intersect ENT, Inc. XENT |
Magnetar Financial LLC | 2,543,999 7.640% |
2,543,999 (New Position) |
Filing History |
| 2021-08-17 3:21 pm Purchase |
2021-08-09 | 13G | Intersect ENT, Inc. XENT |
Versor Investments LP | 1,736,079 5.210% |
1,736,079 (New Position) |
Filing History |
| 2021-06-10 11:37 am Purchase |
2021-06-09 | 13G | Intersect ENT, Inc. XENT |
FMR CORP | 3,495,000 10.545% |
535,000 (+18.07%) |
Filing History |
| 2021-04-09 06:13 am Purchase |
2021-03-31 | 13G | Intersect ENT, Inc. XENT |
Artisan Partners Limited Partnership | 3,768,171 11.400% |
801,723 (+27.03%) |
Filing History |
| 2021-02-12 4:11 pm Sale |
2020-12-31 | 13G | Intersect ENT, Inc. XENT |
HealthCor Management L.P. | 0 0.000% |
-2,536,760 (Position Closed) |
Filing History |
| 2021-02-12 12:35 pm Purchase |
2020-12-31 | 13G | Intersect ENT, Inc. XENT |
Flynn James E | 4,438,213 4.985% |
1,641,180 (+58.68%) |
Filing History |
| 2021-02-10 11:03 am Purchase |
2020-12-31 | 13G | Intersect ENT, Inc. XENT |
The Vanguard Group | 1,665,434 5.090% |
41,468 (+2.55%) |
Filing History |
| 2021-02-10 06:13 am Purchase |
2020-12-31 | 13G | Intersect ENT, Inc. XENT |
Artisan Partners Limited Partnership | 2,966,448 9.100% |
2,966,448 (New Position) |
Filing History |